{
  "protocolSection": {
    "identificationModule": {
      "nctId": "NCT01308021",
      "orgStudyIdInfo": {
        "id": "BTT-gpASIT005"
      },
      "organization": {
        "fullName": "BioTech Tools S.A.",
        "class": "INDUSTRY"
      },
      "briefTitle": "Clinical Efficacy and Safety of gpASIT+TM to Treat Seasonal Allergic Rhinoconjunctivitis",
      "officialTitle": "Clinical Efficacy, Immunogenicity, Clinical Tolerability and Assessment of Safety of gpASIT+TM Administered Orally, According to Two Administration Schedules, for the Prophylaxis of Seasonal Grass Pollen Rhinoconjunctivitis"
    },
    "statusModule": {
      "statusVerifiedDate": "2014-05",
      "overallStatus": "COMPLETED",
      "expandedAccessInfo": {
        "hasExpandedAccess": false
      },
      "startDateStruct": {
        "date": "2010-12"
      },
      "primaryCompletionDateStruct": {
        "date": "2011-10",
        "type": "ACTUAL"
      },
      "completionDateStruct": {
        "date": "2011-12",
        "type": "ACTUAL"
      },
      "studyFirstSubmitDate": "2011-02-28",
      "studyFirstSubmitQcDate": "2011-03-02",
      "studyFirstPostDateStruct": {
        "date": "2011-03-03",
        "type": "ESTIMATED"
      },
      "lastUpdateSubmitDate": "2014-05-23",
      "lastUpdatePostDateStruct": {
        "date": "2014-05-26",
        "type": "ESTIMATED"
      }
    },
    "sponsorCollaboratorsModule": {
      "responsibleParty": {
        "type": "SPONSOR"
      },
      "leadSponsor": {
        "name": "BioTech Tools S.A.",
        "class": "INDUSTRY"
      }
    },
    "oversightModule": {
      "oversightHasDmc": false
    },
    "descriptionModule": {
      "briefSummary": "The purpose of the study is to evaluate the efficacy and safety of grass pollen-derived peptides administrated orally to treat seasonal allergic rhinoconjunctivitis."
    },
    "conditionsModule": {
      "conditions": [
        "Grass Pollen Allergy",
        "Hay Fever"
      ],
      "keywords": [
        "Rhinoconjunctivitis",
        "Allergy",
        "Grass pollen",
        "Hypersensitivity",
        "Immune system disorder"
      ]
    },
    "designModule": {
      "studyType": "INTERVENTIONAL",
      "phases": [
        "PHASE2"
      ],
      "designInfo": {
        "allocation": "RANDOMIZED",
        "interventionModel": "PARALLEL",
        "primaryPurpose": "PREVENTION",
        "maskingInfo": {
          "masking": "DOUBLE",
          "whoMasked": [
            "PARTICIPANT",
            "INVESTIGATOR"
          ]
        }
      },
      "enrollmentInfo": {
        "count": 202,
        "type": "ACTUAL"
      }
    },
    "armsInterventionsModule": {
      "armGroups": [
        {
          "label": "gpASIT400",
          "type": "EXPERIMENTAL",
          "description": "gpASIT+TM 400 µg",
          "interventionNames": [
            "Biological: gpASIT+TM"
          ]
        },
        {
          "label": "gpASIT800",
          "type": "EXPERIMENTAL",
          "description": "gpASIT+TM 800 µg",
          "interventionNames": [
            "Biological: gpASIT+TM"
          ]
        },
        {
          "label": "Placebo",
          "type": "PLACEBO_COMPARATOR",
          "interventionNames": [
            "Biological: Placebo"
          ]
        }
      ],
      "interventions": [
        {
          "type": "BIOLOGICAL",
          "name": "gpASIT+TM",
          "description": "entero-coated capsules containing 400µg of gpASIT+TM, daily , 28 days",
          "armGroupLabels": [
            "gpASIT400"
          ]
        },
        {
          "type": "BIOLOGICAL",
          "name": "gpASIT+TM",
          "description": "entero-coated capsules containing 800 µg of gpASIT+TM, daily, 28 days",
          "armGroupLabels": [
            "gpASIT800"
          ]
        },
        {
          "type": "BIOLOGICAL",
          "name": "Placebo",
          "description": "Placebo entero-coated capsules",
          "armGroupLabels": [
            "Placebo"
          ]
        }
      ]
    },
    "outcomesModule": {
      "primaryOutcomes": [
        {
          "measure": "Impact of gpASIT+TM on the clinical efficacy of the subjects",
          "description": "The following parameter will be assessed: rhinoconjunctivitis total symptom score",
          "timeFrame": "grass pollen season 2011 (April to July)"
        }
      ],
      "secondaryOutcomes": [
        {
          "measure": "Clinical tolerability and safety of the treatment",
          "description": "The following parameters will be assessed: general physical status, vital signs, haematological parameters, general blodd biochemistry parameters, all (serious) adverse events, immunological analysis (total IgG, IgE) and inflammatory parameters (CRP, sedimentation rate)",
          "timeFrame": "8 months"
        },
        {
          "measure": "Impact of gpASIT+TM on the immunological status of the subjects",
          "description": "The following parameter will be assessed: allergen-specific immunoglobulin concentrations",
          "timeFrame": "screening visit (January-February 2011), before pollen season (April 2011), during pollen season (June 2011) and after pollen season (August 2011)"
        },
        {
          "measure": "Impact of gpASIT+TM on the clinical status of the subjects",
          "description": "The average daily symptom and rescue medication scores will be assessed.",
          "timeFrame": "grass pollen season 2011 (April-July)"
        },
        {
          "measure": "Impact of gpASIT+TM on the quality of life of the subjects",
          "description": "The quality of life will be assessed by the use of validated questionnaires.",
          "timeFrame": "grass pollen season 2011 (April-July)"
        }
      ]
    },
    "eligibilityModule": {
      "eligibilityCriteria": "Inclusion Criteria:\n\n* Age between 18 and 50 years\n* Subject has given written informed consent\n* The subjects are in good physical and mental health according to his/her medical history, vital signs, and clinical status\n* Male or non pregnant, non-lactating female\n* Female unable to bear children must have documentation of such in the CRF (i.e. tubule ligation, hysterectomy, or post menopausal (defined as a minimum of one year since the last menstrual period))\n* Allergy \\> 2 years\n\nExclusion Criteria:\n\n* Subjects with current immunotherapy or subjects who underwent a previous immunotherapy within the last 2 years\n* Subjects with perennial asthma\n* Subjects with a VC \\< 80% and FEV1 \\< 70%\n* Subjects requiring controller medication against asthma (bronchodilator nebulised drugs or local or systemic corticosteroids)\n* Documented evidence of chronic sinusitis (as determined by investigator)\n* Subjects with a history of hepatic or renal disease\n* Subjects symptomatic to perennial inhalant allergens\n* Subject with malignant disease, autoimmune disease\n* Female subjects who are pregnant, lactating, or of child-bearing potential and not protected from pregnancy by a sufficiently reliable method (OCs, IUD, ...)\n* Any chronic disease, which may impair the subject's ability to participate in the trial (i.e. severe congestive heart failure, active gastric ulcer, inflammatory bowel disease, uncontrolled diabetes mellitus, etc…)\n* Subjects requiring beta-blockers medication\n* Chronic use of concomitant medications that would affect assessment of the effectiveness of the trial medication (e.g. tricyclic antidepressants)\n* Subject with febrile illness (\\> 37.5°C, oral)\n* A known positive serology for HIV-1/2, HBV or HCV\n* The subject is immunocompromised by medication or illness, has received a vaccine, corticoids or immunosuppressive medications within 1 month before trial entry\n* Receipt of blood or a blood derivative in the past 6 months preceding trial entry\n* Regular consumption of corticoids (oral, topic or nasal) or of anti-histaminic drugs within 4 weeks preceding the trial\n* Any consumption of corticoids (oral, topic or nasal) or of anti-histaminic drugs within 1 week preceding the trial\n* Use of long-acting antihistamines\n* Any condition which could be incompatible with protocol understanding and compliance\n* Subjects who have forfeited their freedom by administrative or legal award or who are under guardianship\n* Unreliable subjects including non-compliant subjects, subjects with known alcoholism or drug abuse or with a history of a serious psychiatric disorder as well as subjects unwilling to give informed consent or to abide by the requirements of the protocol\n* Participation in another clinical trial and/or treatment with an experimental drug within the last 2 years\n* A history of hypersensitivity to the excipients\n* Rhinitis medicamentosa, non-specific rhinitis (to food dye, preservative agent…)\n* Subjects without means of contacting the investigator rapidly in case of emergency, or not able to be contacted rapidly by the investigator",
      "healthyVolunteers": false,
      "sex": "ALL",
      "minimumAge": "18 Years",
      "maximumAge": "50 Years",
      "stdAges": [
        "ADULT"
      ]
    },
    "contactsLocationsModule": {
      "overallOfficials": [
        {
          "name": "Claus Bachert, MD",
          "affiliation": "UZ Ghent",
          "role": "PRINCIPAL_INVESTIGATOR"
        },
        {
          "name": "Jan Ceuppens, MD",
          "affiliation": "UZ Leuven",
          "role": "PRINCIPAL_INVESTIGATOR"
        },
        {
          "name": "Didier Ebo, MD",
          "affiliation": "UZ Antwerpen",
          "role": "PRINCIPAL_INVESTIGATOR"
        },
        {
          "name": "Jean-Luc Halloy, MD",
          "affiliation": "CHR Warquignies",
          "role": "PRINCIPAL_INVESTIGATOR"
        },
        {
          "name": "Stijn Hallewyck, MD",
          "affiliation": "Universitair Ziekenhuis Brussel",
          "role": "PRINCIPAL_INVESTIGATOR"
        },
        {
          "name": "Peter Hellings, MD",
          "affiliation": "UZ Leuven",
          "role": "PRINCIPAL_INVESTIGATOR"
        },
        {
          "name": "Renaud Louis, MD",
          "affiliation": "Centre Hospitalier Universitaire de Liege",
          "role": "PRINCIPAL_INVESTIGATOR"
        },
        {
          "name": "Catherine Mbasoa, MD",
          "affiliation": "Clinique du Parc Léopold Bruxelles",
          "role": "PRINCIPAL_INVESTIGATOR"
        },
        {
          "name": "Charles Pilette, MD",
          "affiliation": "UCL Saint Luc Bruxelles",
          "role": "PRINCIPAL_INVESTIGATOR"
        },
        {
          "name": "Hélène Simonis, MD",
          "affiliation": "CHR Citadelle Liège",
          "role": "PRINCIPAL_INVESTIGATOR"
        },
        {
          "name": "Olivier Vandenplas, MD",
          "affiliation": "UCL Mont Godinne Yvoir",
          "role": "PRINCIPAL_INVESTIGATOR"
        },
        {
          "name": "Christoph Verhoye, MD",
          "affiliation": "AZ Sint-Lucas Brugge",
          "role": "PRINCIPAL_INVESTIGATOR"
        },
        {
          "name": "Patricia Wackenier, MD",
          "affiliation": "CHU Ambroise-Paré - Mons",
          "role": "PRINCIPAL_INVESTIGATOR"
        },
        {
          "name": "Frédéric De Blay, MD",
          "affiliation": "CHRU Strasbourg",
          "role": "PRINCIPAL_INVESTIGATOR"
        },
        {
          "name": "Marie-Christine Castelain, MD",
          "affiliation": "Hôpital Saint Vincent de Paul, Lille",
          "role": "PRINCIPAL_INVESTIGATOR"
        },
        {
          "name": "François Lavaud, MD",
          "affiliation": "CHRU Reims",
          "role": "PRINCIPAL_INVESTIGATOR"
        },
        {
          "name": "Benoît Wallaert, MD",
          "affiliation": "CHU Lille",
          "role": "PRINCIPAL_INVESTIGATOR"
        },
        {
          "name": "François Wessel, MD",
          "affiliation": "Private Practice Nantes",
          "role": "PRINCIPAL_INVESTIGATOR"
        },
        {
          "name": "Bruno Lebeaupin, MD",
          "affiliation": "Private Practice Nantes",
          "role": "PRINCIPAL_INVESTIGATOR"
        },
        {
          "name": "François Hentges, MD",
          "affiliation": "CHL Luxembourg",
          "role": "PRINCIPAL_INVESTIGATOR"
        },
        {
          "name": "François Durand Perdriel, MD",
          "affiliation": "Private Practice Nantes",
          "role": "PRINCIPAL_INVESTIGATOR"
        },
        {
          "name": "François Spirlet, MD",
          "affiliation": "CH de Dinant",
          "role": "PRINCIPAL_INVESTIGATOR"
        }
      ],
      "locations": [
        {
          "facility": "CHR Saint Joseph Warquignies",
          "city": "Boussu",
          "zip": "7300",
          "country": "Belgium",
          "geoPoint": {
            "lat": 50.43417,
            "lon": 3.7944
          }
        },
        {
          "facility": "AZ Sint Lucas",
          "city": "Bruges",
          "zip": "8310",
          "country": "Belgium",
          "geoPoint": {
            "lat": 51.20892,
            "lon": 3.22424
          }
        },
        {
          "facility": "Clinique du Parc Léopold",
          "city": "Brussels",
          "zip": "1040",
          "country": "Belgium",
          "geoPoint": {
            "lat": 50.85045,
            "lon": 4.34878
          }
        },
        {
          "facility": "UZ Brussel",
          "city": "Brussels",
          "zip": "1090",
          "country": "Belgium",
          "geoPoint": {
            "lat": 50.85045,
            "lon": 4.34878
          }
        },
        {
          "facility": "UCL Saint Luc",
          "city": "Brussels",
          "zip": "1200",
          "country": "Belgium",
          "geoPoint": {
            "lat": 50.85045,
            "lon": 4.34878
          }
        },
        {
          "facility": "UZ Antwerpen",
          "city": "Edegem",
          "zip": "2650",
          "country": "Belgium",
          "geoPoint": {
            "lat": 51.15662,
            "lon": 4.44504
          }
        },
        {
          "facility": "UZ Gent",
          "city": "Ghent",
          "zip": "9000",
          "country": "Belgium",
          "geoPoint": {
            "lat": 51.05,
            "lon": 3.71667
          }
        },
        {
          "facility": "UZ Leuven",
          "city": "Leuven",
          "zip": "3000",
          "country": "Belgium",
          "geoPoint": {
            "lat": 50.87959,
            "lon": 4.70093
          }
        },
        {
          "facility": "CHR Citadelle",
          "city": "Liège",
          "zip": "4000",
          "country": "Belgium",
          "geoPoint": {
            "lat": 50.63373,
            "lon": 5.56749
          }
        },
        {
          "facility": "CHU Sart-Tilman",
          "city": "Liège",
          "zip": "4000",
          "country": "Belgium",
          "geoPoint": {
            "lat": 50.63373,
            "lon": 5.56749
          }
        },
        {
          "facility": "CHU Ambroise Paré",
          "city": "Mons",
          "zip": "7000",
          "country": "Belgium",
          "geoPoint": {
            "lat": 50.45413,
            "lon": 3.95229
          }
        },
        {
          "facility": "UCL Mont Godinne",
          "city": "Yvoir",
          "zip": "5530",
          "country": "Belgium",
          "geoPoint": {
            "lat": 50.3279,
            "lon": 4.88059
          }
        },
        {
          "facility": "Hôpital Saint Vincent de Paul",
          "city": "Lille",
          "zip": "59020",
          "country": "France",
          "geoPoint": {
            "lat": 50.63391,
            "lon": 3.05512
          }
        },
        {
          "facility": "CHRU Lille",
          "city": "Lille",
          "zip": "59037",
          "country": "France",
          "geoPoint": {
            "lat": 50.63391,
            "lon": 3.05512
          }
        },
        {
          "facility": "Private practice",
          "city": "Nantes",
          "zip": "44000",
          "country": "France",
          "geoPoint": {
            "lat": 47.21725,
            "lon": -1.55336
          }
        },
        {
          "facility": "Private practice",
          "city": "Nantes",
          "zip": "44400",
          "country": "France",
          "geoPoint": {
            "lat": 47.21725,
            "lon": -1.55336
          }
        },
        {
          "facility": "CHU Reims",
          "city": "Reims",
          "zip": "51100",
          "country": "France",
          "geoPoint": {
            "lat": 49.26526,
            "lon": 4.02853
          }
        },
        {
          "facility": "CHRU Strasbourg",
          "city": "Strasbourg",
          "zip": "67091",
          "country": "France",
          "geoPoint": {
            "lat": 48.58392,
            "lon": 7.74553
          }
        },
        {
          "facility": "CH Luxembourg",
          "city": "Luxembourg",
          "zip": "1210",
          "country": "Luxembourg",
          "geoPoint": {
            "lat": 49.60982,
            "lon": 6.13268
          }
        }
      ]
    }
  },
  "derivedSection": {
    "miscInfoModule": {
      "versionHolder": "2026-02-04"
    },
    "conditionBrowseModule": {
      "meshes": [
        {
          "id": "D006255",
          "term": "Rhinitis, Allergic, Seasonal"
        },
        {
          "id": "D006967",
          "term": "Hypersensitivity"
        },
        {
          "id": "D007154",
          "term": "Immune System Diseases"
        }
      ],
      "ancestors": [
        {
          "id": "D065631",
          "term": "Rhinitis, Allergic"
        },
        {
          "id": "D012220",
          "term": "Rhinitis"
        },
        {
          "id": "D009668",
          "term": "Nose Diseases"
        },
        {
          "id": "D012140",
          "term": "Respiratory Tract Diseases"
        },
        {
          "id": "D012130",
          "term": "Respiratory Hypersensitivity"
        },
        {
          "id": "D010038",
          "term": "Otorhinolaryngologic Diseases"
        },
        {
          "id": "D006969",
          "term": "Hypersensitivity, Immediate"
        }
      ]
    }
  },
  "hasResults": false
}